Q4 2017

Filed Feb 27, 2018 · 10-K · 58 days after period end · 0001564590-18-003508

Q4 2017 · 10-K

derived · Computed from the longer spans the company filed.

Revenue

$30.74M

derived−13.5% vs Q4 2016

Net Income

-$33.89M

derivedN/M vs Q4 2016

EPS, diluted—

Same quarter

Metric	Q4 2017derived from reported figures	Q4 2016derived from reported figures	Q4 2015derived from reported figures	Q4 2014derived from reported figures
Revenue	$30.74M	$35.53M	$24.44M	$16.11M
Net Income	-$33.89M	-$30.39M	-$51.37M	-$50.56M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Kyntra Bio, Inc. · CIK 921299 · Engraved from SEC EDGAR